• No results found

Molecular Biotechnology Programme Uppsala University School of Engineering UPTEC X 01 019

N/A
N/A
Protected

Academic year: 2022

Share "Molecular Biotechnology Programme Uppsala University School of Engineering UPTEC X 01 019"

Copied!
1
0
0

Loading.... (view fulltext now)

Full text

(1)

Molecular Biotechnology Programme Uppsala University School of Engineering

UPTEC X 01 019

Date of issue 2001-04-07

Author

Martin Millbourn

Title (English)

E-business in the pharmaceutical industry

Presentation of a solution, based on mobile Internet, for electronic data capture in clinical trials

Title (Swedish) Abstract

Solutions for electronic data capture during the clinical trial conduct in the pharmaceutical industry have been investigated. A mobile system where patients and investigators are using connected, pen-based handheld computers with back-lit display in color is presented. The solution consists of handheld computers, a polling server and a webpage where monitors and investigators can reach the on-line registered data that presents information about the trial conduct. The system is able to streamline the whole process by eliminating problems coming from missing entries, poor handwriting, query processing, time consuming monitor travelling and document transportation. Additionally, a range of side-products such as recruitment systems and knowledge management systems will come from having all data collected and stored electronically in a central database.

Keywords

Clinical trials, e-business, handheld computers, mobile Internet, business strategies Supervisors

Gunilla Orrebrink

Adera Examiner

Matti Nikkola

Uppsala universitet

Project name Sponsors

Language

English

Security

ISSN 1401-2138 Classification

Supplementary bibliographical information Pages

61

Biology Education Centre Biomedical Center Husargatan 3 Uppsala Box 592 S-75124 Uppsala Tel +46 (0)18 4710000 Fax +46 (0)18 555217

References

Related documents

Platelet derived growth factor (PDGF) and its receptors are involved in signal transduction and over expression of PDGF and both receptors has been shown in several tumors.

The intrinsic property of PARN to bind 5'cap structure of mRNA was further studied. Two PARN mutants were created by site

This work is aimed at qualitatively elucidating the important chemical interactions between anti-cancer drug cisplatin and its target DNA by means of the Quantum Chemical method

coli as the host organism was developed and used for studying protein-protein interactions in the gram positive pathogen Staphylococcus

pylori in the coccoidal form, mRNA-levels in a large quantity of Helicobacter pylori genes were detected using the microarray technique. For this purpose 85

The aim of this study was to investigate how the RNA-binding proteins poly(A) binding protein (PABP) and p100 affect the activity of PARN. Recombinant PABP, p100 and PARN was

We have performed molecular dynamics simulations of the ground-, K- and L-state structures of the bacteriorhodopsin proton pump-cycle, and mapped the hydrogen-bond networks. Our

Molecular Biotechnology Programme Uppsala University School of Engineering UPTEC X 01 026 Date of issue